eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
2/2018
vol. 5
 
Share:
Share:
more
 
 
abstract:
Guidelines/recommendations

Venom immunotherapy

Marita Nittner-Marszalska

Alergologia Polska – Polish Journal of Allergology 2018; 5, 2: 85–93
Online publish date: 2018/06/27
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Allergen immunotherapy (AIT) in patients with moderate and severe allergic symptoms to insect venom (Hymenoptera venom allergy – HVA) significantly reduces the risk of severe reactions to subsequent sting and improves the patient’s quality of life. Allergen immunotherapy in HVA is also advantageous for pharmacoeconomic reasons. Allergen immunotherapy is recommended for HVA patients with life threatening reactions to sting. The therapy can be recommended for subjects with non-life threatening reactions in cases such as: high-risk exposure to sting (e.g. beekeepers), concomitance of diseases increasing the risk of severe reactions to subsequent stings, and/or limited access to specialized medical care. Qualification for VIT is based on clinical criteria and diagnostic tests confirming the presence of sIgE to insect venom. Molecular diagnosis can be helphul in HVA diagnosis. Venom immunotherapy is absolutely contraindicated in uncontrolled asthma, active phases of autoimmunological and neoplastic diseases, AIDS, and in children under two years of age. Venom immunotherapy must not be started in pregnancy. In patients with severe HVA reactions, baseline serum tryptase (bsT) test should be performed. It is recommended that bsT test should be performed again before the planned completion of VIT. Patients qualified for VIT should undergo a general medical examination. Complications in the course of VIT are more frequent in the induction than the maintenance phase and their frequency is similar to that of the occurrence of complications in inhalant allergen immunotherapy.
keywords:

Hymenoptera venom allergy, insect venom immunotherapy, tryptase, adrenaline autoinjector



Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe